Reports October 2017



Evaluation of the Drugs and Alcohol Recovery Payment by Results Pilot Programme Final Report (PDF)

In April 2012, eight commissioning areas initiated a pilot scheme whereby a proportion of provider payments were linked to achievement of specified outcomes representing recovery from problems relating to drugs and alcohol misuse by service users. The purpose of the Payment by Results Pilots was to both develop and test this new approach to the commissioning and delivery of drugs and alcohol services. This report describes an evaluation of the scheme | Manchester University, UK

Health Matters: preventing ill health from alcohol and tobacco use

This professional resource focuses on preventing ill health caused by alcohol and tobacco use and makes the case for why NHS providers should implement the ‘preventing ill health by risky behaviours – alcohol and tobacco | PHE, UK

Implementing 'Preventing ill health by risky behaviours'

This commissioning for quality and innovation (CQUIN) allows South London and Maudsley NHS Foundation Trust to refocus on alcohol screening and interventions | PHE, UK

Drug-related deaths involving nitrous oxide, 1993 to 2015

Number of drug-related deaths where nitrous oxide was mentioned on the death certificate, 1993 to 2015 registrations | ONS, UK

Changing behaviour: Electronic cigarettes (PDF)

This briefing summarises the facts and figures around smoking cessation and the use of e-cigarettes for behaviour change in adults followed by public policy recommendations to facilitate smoking cessation | BPS, UK

Fentanyl Report (PDF)

In September 2017 CGL and Volteface convened a ‘round table’ to discuss responses to the growing threat posed by fentanyl and its analogues (often referred to as ‘fentalogues’ or ‘fentanyls’)... The round table followed reports of at least 60 deaths linked to fentanyls in England and Wales in the previous eight months and CGL’s direct experience of managing outbreaks of fentanyl-related overdose deaths in two areas in England | CGL, UK

Evaluating drug policy: a seven-step guide to support the commissioning and managing of evaluations

This document summarises the main issues concerning evaluation in the field of drug policy. Aimed at those managing rather than undertaking drug policy evaluations, the guide acts as an introduction, providing links to the wider literature. Recognising that there is no single correct way to undertake an evaluation, this publication is designed to assist people in choosing the best approach to suit their circumstances and to maximise the value of any evaluation | EMCCDA, Portugal

Health and social responses to drug problems: a European guide

This guide and the associated package of online materials provides a reference point for planning or delivering health and social responses to drug problems in Europe. The most appropriate responses will depend on the specific drug problems, the contexts in which these occur and the types of intervention that are possible and socially acceptable. By providing key information on some of the most important drug issues for Europe and the responses available, this guide aims to assist those involved in tackling these challenges to develop new programmes and improve existing ones | EMCDDA, Portugal

Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWID in London (PDF)

These recommendations reflect those made by the LJWG in its publication Commissioning of hepatitis C (HCV) services in London for People Who Inject Drugs report from 2013i (1) suggesting that there is still significant action and progress needed to increase access to HCV treatment | LJWG, UK

Criminal Justice Project: Drug Interventions Programme – Re-offending of clients testing positive for class A drugs across Merseyside

The link between illicit drug use and crime has been well researched (Pierce et al., 2015; Hayhurst et al., 2013; Bennett et al., 2008; Seddon, 2000). The Drug Interventions Programme (DIP) is a multi-agency initiative with an overarching aim to break the cycle of drug use and crime, and as a result reduce acquisitive crime in communities within England and Wales | PHI, UK

National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (PDF)

Includes statistics on alcohol and other drug use | Manchester University, UK

Drugs-related deaths rapid evidence review: Keeping people safe (PDF)

In July 2017 the Scottish Government and the Partnership for Action on Drugs in Scotland (PADS) convened a conference entitled Drug Policy through a Health Lens, to respond to rising drug-related deaths in Scotland. NHS Health Scotland undertook a rapid evidence review to inform the discussions taking place at the conference. The initial findings of the review were presented at the conference. This report presents the evidence base which underpinned that conference presentation | NHS Health Scotland, UK

Street Lottery: Cannabis Potency and Mental Health

This report provides a concise and compelling new account of the deleterious consequences of leaving cannabis in the hands of the black market. Drawing on insights from world class academics and original research, it was commissioned to stimulate a better informed and more nuanced public debate | Volte Face, UK

National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (PDF)

Includes statistics on alcohol and other drug use | Manchester University, UK

Wheel of Misfortune: The case for lowering the stakes on Fixed Odds Betting Terminals (PDF)

This is a key moment in the debate over the regulation of Fixed Odds Betting Terminals (FOBTs) in Britain today. We remain the only country in the developed world that allows up to £100 to be staked every 20 seconds on casinostyle gaming machines on our high streets. The Department for Digital, Culture, Media and Sport (DCMS) is currently looking at the regulation of FOBTs as part of a wider review into gaming machines, with the findings of this review due to be announced in the Autumn | Respublica, UK

How to estimate the cost of drug treatment in Europe?

It is estimated that over 1 million people receive treatment for drug-related problems in the European Union every year. With shrinking public budgets, increasing pressure on health systems, changes in the substances used and the need to provide ongoing care to chronic cases, how can we estimate the cost of drug treatment in Europe? | EMCDDA, Portugal

Substance misuse statistics

hese reports include statistics from the Welsh National Database for Substance Misuse and additional substance misuse related information available from routinely published sources in Wales | STAT Wales, UK

The impact of using the new definition of alcohol-specific deaths

This article communicates the new definition of alcohol-specific deaths, the reasons for it and its impact on the existing time series of alcohol-related deaths | ONS, UK

Stoptober 2016 campaign evaluation

Stoptober is a major annual event to encourage smokers to quit for 28 days in October - with the aim of stopping smoking permanently. This document measures the impact of Stoptober in 2016, its fifth year of operation | PHE, UK

Hepatitis B: guidance, data and analysis

Hepatitis B virus (HBV) is a viral infection carried in the blood causing inflammation of the liver and potentially long term damage. The virus is transmitted by contact with an infected person’s blood or body fluids. Hepatitis B is vaccine preventable | PHE, UK

Women who use drugs: Issues, needs, responses, challenges and implications for policy and practice (PDF)

In the European Union 34.8 million women aged 15 to 64 are reported to have ever tried an illicit drug, compared with 54.3 million men | EMCDDA, Portugal

User-led interventions: an expanding resource? (PDF)

This short paper outlines the growth of user-led interventions across Europe in the problem (as opposed to recreational) drug sector over recent years. It starts by attempting to define and categorise user-led interventions before describing a number of examples and sharing what is known about their effectiveness. The paper concludes by identifying likely developments, highlighting the opportunities created by user-led work and detailing the challenges for policymakers and commissioners in Europe | EMCCDA, Portugal

America’s Opioid Epidemic: From Evidence to Impact (PDF)

The U.S. is experiencing its highest-ever rates of opioid addiction and overdose, and the numbers are only predicted to rise. A combination of the overuse of prescription opioids for acute and chronic pain and an increasing supply of heroin and illicit fentanyl is driving this epidemic | John Hopkins, USA

Global Synthetic Drugs Assessment: Amphetamine-type stimulants and new psychoactive substances (PDF)

Unlike the manufacture of heroin and cocaine, the manufacture of synthetic drugs is not geographically constrained, as the process does not involve the extraction of active constituents from plants that have to be cultivated in certain conditions for them to grow. Yet any analysis of the synthetic drugs market is complicated by the fact that information on synthetic drug manufacture is limited, which prevents the estimation of the volume of such drugs being manufactured worldwide. Nevertheless, data on seizures and use suggest that the supply of synthetic drugs is expanding | UNODC, Austria

Mental Health Act 1983: implementing changes to police powers

[Notes that the new maximum period of detention of 24 hours can be extended up to a further 12 hours if it is not practicable to complete a Mental Health Act assessment within the 24 hour period. This might arise, for example, if the person is too mentally distressed, or is particularly intoxicated with alcohol or drugs and cannot co-operate with the assessment process] | Department of Health and Home Office, UK

Deaths and serious incidents in police custody: government response

[Includes mention of drugs - Drugs and/or alcohol also featured as causes in around half of deaths (49%), and an even higher proportion of those who died had an association with drugs or alcohol (82%) ] | Home Office, UK

Government to take action on Fixed Odds Betting Terminals

Gambling Minister Tracey Crouch launches 12-week consultation on stake reduction to better protect consumers and communities | Department for Digital, Culture, Media & Sport and Tracey Crouch MP, UK

User-led interventions: an expanding resource?

This short paper outlines the growth of user-led interventions across Europe in the problem (as opposed to recreational) drug sector over recent years. It starts by attempting to define and categorise user-led interventions before describing a number of examples and sharing what is known about their effectiveness | EMCDDA, Portugal

Policy and practice briefings: Vulnerable young people

Many young people experiment with drugs but only a minority become dependent on drugs in young adulthood. Those who are most vulnerable to drug dependence are socially disadvantaged young people and those having family members and peers who use drugs | EMCDDA, Portugal

Responding to the needs of ageing drug users

Older people with drug problems (OPDP) are considered those aged 40 or over whose recurrent drug use is causing them harm or is placing them at a high risk of such harm OPDP are likely to encounter negative life outcomes due to their drug use and they have characteristics and trajectories distinct from those of their younger counterparts | EMCDDA, Portugal









Home : Terms of use : Contact
Copyright DrugWise©2016